Recent

% | $
Quotes you view appear here for quick access.

Metropolitan Health Networks Inc. Message Board

schroe_us 66 posts  |  Last Activity: 14 hours ago Member since: Jan 30, 2001
  • Reply to

    New paper mentioning solithromycin

    by kiddo1428 Jun 18, 2015 1:33 PM
    schroe_us schroe_us Jun 18, 2015 3:56 PM Flag

    STD? No problem…..
    The MIC of solithromycin was correlated with mutations in the 23S rRNA gene and in the genes encoding ribosomal proteins L4 and L22. The in vitro results showed that solithromycin has activity against M. genitalium superior to that of other macrolides, doxycycline, and fluoroquinolones.

  • Reply to

    New paper mentioning solithromycin

    by kiddo1428 Jun 18, 2015 1:33 PM
    schroe_us schroe_us Jun 18, 2015 3:51 PM Flag

    Nice find. my favorite Abstract is:
    Solithromycin, a next-generation macrolide and novel fluoroketolide, was tested against a 2012 collection of serotyped U.S. macrolide-resistant Streptococcus pneumoniae isolates associated with community-acquired bacterial pneumonia (CABP). Against all 272 isolates, solithromycin demonstrated high potency (MIC50/90, 0.06/0.25 μg/ml), and it inhibited all strains at MICs of ≤0.5 μg/ml, including the two most prevalent macrolide-resistant serotypes (19A and 35B). These data support the continued clinical development of solithromycin for the treatment of multidrug-resistant CABP.

  • Every sell off puts shares in much stronger hands. The chart lines up nicely with the coming catalysts . I see 35 as the mendosa line . It may never drop below it ever again once it rises above it. A huge bio sell off would be the only problem but I would just buy more. Like I did at 32 two days ago. Enjoy the summer.

  • Reply to

    Clinicaltrials.gov updated for IV to Oral trial

    by lennox64 Jun 16, 2015 12:56 PM
    schroe_us schroe_us Jun 16, 2015 6:07 PM Flag

    I love Prabha and trust her greatly but if she has a fault it is that she has been off on her timing of a few catalysts. Im not really complaining as there were huge sell offs of the PPS in the past due to these slight delays which I was happy to take huge advantage of. If we truly have all the Soli IV data at the end on 2015 then buying heavy on any big dip due to this news bite would be like "money in the bank." Gono should be on schedule and could pop the PPS in a big way as well.

  • Reply to

    Limit CEMP to 5% of a portfolio.

    by milwaukee1961 Jun 12, 2015 2:38 PM
    schroe_us schroe_us Jun 15, 2015 3:58 PM Flag

    um….those sectors are wayyyy over bought and may be hitting highs that will never be seen again for a cple of years. Cemp? Well….. it is way over sold and has Soli…..an already proven billion dollar drug that is being washed out with all the small,unproven ,speculative bio companys. The investors here are to smart for your pumping. And for what its worth, I have 95% of my $$$$ in Cemp and sleep very well thank you.

  • Reply to

    Mo Mo Players Hasta La Vista----Bah Bye

    by golongn2008 Jun 10, 2015 11:03 PM
    schroe_us schroe_us Jun 11, 2015 10:38 AM Flag

    Funds are waiting,drooling,praying for a pull back in Cemp. Cemp gets bid up in a fury when it visits the low 30's. I suggest that everyone else does the same. Buy a car for the wife for Christmas instead of a dish washer. Cheers.